Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$189.91
À la fermeture: Oct 20 EDT
$190.23
0.320.17%
Pré-commercialisation: 7:18 PM EDT
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
Marsh & McLennan Companies Inc a un objectif de cours consensus de $221.82, basé sur les évaluations des 23 analystes. Le plus élevé est de $257 attribué par UBS le octobre 8, 2025, et le plus bas est de $172 attribué par Credit Suisse le janvier 30, 2023. Les 3 dernières évaluations d'analystes ont été publiées par Goldman Sachs, Evercore ISI Group et Wells Fargo le octobre 20, 2025, octobre 17, 2025 et octobre 17, 2025. Avec un objectif de cours moyen de $214.67 entre Goldman Sachs, Evercore ISI Group et Wells Fargo, il y a une variation implicite de 12.85% upside pour Marsh & McLennan Companies Inc à partir de ces dernières évaluations d'analystes.
Sociétés d'analyse émettant des recommandations1
Goldman Sachs
Evercore ISI Group
Wells Fargo
Keefe, Bruyette & Woods
JP Morgan
1calculé à partir des notes des analystes
Notes d'analystes pour Marsh & McLennan Cos
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/20/2025 | 2.51% | Goldman Sachs | $200 → $195 | Upgrade | Sell → Neutral | |||
10/17/2025 | 24.59% | Evercore ISI Group | $243 → $237 | Maintains | Outperform | |||
10/17/2025 | 11.44% | Wells Fargo | $222 → $212 | Maintains | Equal-Weight | |||
10/17/2025 | 0.4% | Keefe, Bruyette & Woods | $209 → $191 | Upgrade | Underperform → Market Perform | |||
10/09/2025 | 27.21% | JP Morgan | $248 → $242 | Upgrade | Neutral → Overweight | |||
10/08/2025 | 35.1% | UBS | $258 → $257 | Maintains | Buy | |||
10/08/2025 | 16.18% | Barclays | $233 → $221 | Maintains | Equal-Weight | |||
10/08/2025 | 16.7% | Wells Fargo | $226 → $222 | Maintains | Equal-Weight | |||
10/07/2025 | 13.02% | Morgan Stanley | $220 → $215 | Maintains | Equal-Weight | |||
09/16/2025 | — | Wolfe Research | — | Initiates | → Peer Perform | |||
08/18/2025 | 15.65% | Morgan Stanley | $225 → $220 | Maintains | Equal-Weight | |||
08/13/2025 | 18.8% | Citigroup | → $226 | Initiates | → Neutral | |||
07/21/2025 | 35.63% | UBS | $261 → $258 | Maintains | Buy | |||
07/21/2025 | 10.39% | Keefe, Bruyette & Woods | $214 → $210 | Maintains | Underperform | |||
07/18/2025 | 18.8% | Wells Fargo | $229 → $226 | Maintains | Equal-Weight | |||
07/10/2025 | 20.38% | Wells Fargo | $228 → $229 | Maintains | Equal-Weight | |||
07/09/2025 | 12.5% | Keefe, Bruyette & Woods | $215 → $214 | Maintains | Underperform | |||
07/07/2025 | 22.48% | Barclays | $249 → $233 | Maintains | Equal-Weight | |||
04/21/2025 | 13.02% | Keefe, Bruyette & Woods | $220 → $215 | Maintains | Underperform | |||
04/11/2025 | 30.89% | Barclays | $246 → $249 | Maintains | Equal-Weight | |||
04/11/2025 | 28.27% | Jefferies | $237 → $244 | Maintains | Hold | |||
04/10/2025 | 21.96% | Wells Fargo | $223 → $232 | Maintains | Equal-Weight | |||
04/09/2025 | 37.2% | UBS | $259 → $261 | Maintains | Buy | |||
04/09/2025 | 15.65% | Keefe, Bruyette & Woods | $210 → $220 | Maintains | Underperform | |||
02/06/2025 | 31.42% | Raymond James | $240 → $250 | Reiterates | Outperform → Outperform | |||
02/03/2025 | 10.39% | Keefe, Bruyette & Woods | $214 → $210 | Maintains | Underperform | |||
01/31/2025 | 17.23% | Wells Fargo | $212 → $223 | Maintains | Equal-Weight | |||
01/10/2025 | 12.5% | Keefe, Bruyette & Woods | $212 → $214 | Maintains | Underperform | |||
01/03/2025 | 23.53% | JP Morgan | $230 → $235 | Maintains | Neutral | |||
12/12/2024 | 31.42% | RBC Capital | $242 → $250 | Upgrade | Sector Perform → Outperform | |||
11/25/2024 | 27.21% | Evercore ISI Group | → $242 | Reinstates | → Outperform | |||
11/21/2024 | 29.32% | Barclays | $236 → $246 | Maintains | Equal-Weight | |||
10/22/2024 | 19.85% | BMO Capital | $217 → $228 | Maintains | Market Perform | |||
10/22/2024 | 36.15% | UBS | $255 → $259 | Maintains | Buy | |||
10/22/2024 | 11.44% | Keefe, Bruyette & Woods | $209 → $212 | Maintains | Underperform | |||
10/21/2024 | 11.44% | Wells Fargo | $211 → $212 | Maintains | Equal-Weight | |||
10/18/2024 | 20.91% | Roth MKM | $220 → $230 | Maintains | Neutral | |||
10/18/2024 | 27.21% | RBC Capital | $232 → $242 | Maintains | Sector Perform | |||
10/10/2024 | 31.42% | B of A Securities | $248 → $250 | Maintains | Neutral | |||
10/10/2024 | 10.92% | Wells Fargo | $212 → $211 | Maintains | Equal-Weight | |||
10/09/2024 | 16.7% | Jefferies | $219 → $222 | Maintains | Hold | |||
10/01/2024 | 30.37% | B of A Securities | $235 → $248 | Maintains | Neutral | |||
09/04/2024 | 24.06% | Barclays | → $236 | Initiates | → Equal-Weight | |||
07/19/2024 | 21.96% | RBC Capital | $228 → $232 | Maintains | Sector Perform | |||
07/19/2024 | 15.65% | Roth MKM | $200 → $220 | Maintains | Neutral | |||
07/11/2024 | 20.91% | JP Morgan | $210 → $230 | Maintains | Neutral | |||
06/28/2024 | 19.85% | RBC Capital | $210 → $228 | Maintains | Sector Perform | |||
05/22/2024 | 22.48% | B of A Securities | $223 → $233 | Maintains | Neutral | |||
04/22/2024 | 5.66% | TD Cowen | $189 → $201 | Maintains | Hold | |||
04/22/2024 | 25.11% | UBS | $236 → $238 | Maintains | Buy | |||
04/19/2024 | 17.23% | B of A Securities | $228 → $223 | Maintains | Neutral | |||
04/19/2024 | 10.39% | RBC Capital | $208 → $210 | Maintains | Sector Perform | |||
04/19/2024 | 11.97% | Wells Fargo | $212 → $213 | Maintains | Equal-Weight | |||
04/19/2024 | 9.34% | Jefferies | $197 → $208 | Maintains | Hold | |||
04/17/2024 | 10.92% | Piper Sandler | → $211 | Downgrade | Overweight → Neutral | |||
04/15/2024 | 10.39% | Morgan Stanley | $205 → $210 | Maintains | Equal-Weight | |||
04/11/2024 | 11.44% | Wells Fargo | → $212 | Downgrade | Overweight → Equal-Weight | |||
04/11/2024 | 14.6% | Evercore ISI Group | $212 → $218 | Maintains | Outperform | |||
04/10/2024 | -1.17% | Keefe, Bruyette & Woods | $185 → $188 | Maintains | Underperform | |||
04/08/2024 | 4.08% | JP Morgan | $190 → $198 | Maintains | Neutral | |||
01/30/2024 | -2.75% | Keefe, Bruyette & Woods | $186 → $185 | Maintains | Underperform | |||
01/26/2024 | 9.34% | RBC Capital | $200 → $208 | Maintains | Sector Perform | |||
01/09/2024 | -2.75% | Goldman Sachs | $215 → $185 | Maintains | Sell | |||
01/08/2024 | — | Goldman Sachs | — | Downgrade | Buy → Sell | |||
12/15/2023 | 0.93% | Keefe, Bruyette & Woods | $198 → $192 | Downgrade | Market Perform → Underperform | |||
10/20/2023 | 5.14% | RBC Capital | $195 → $200 | Maintains | Sector Perform | |||
10/20/2023 | 7.76% | Citigroup | $201 → $205 | Maintains | Neutral | |||
10/20/2023 | 10.39% | Raymond James | $205 → $210 | Maintains | Outperform | |||
10/11/2023 | 13.02% | Morgan Stanley | $205 → $215 | Maintains | Equal-Weight | |||
10/06/2023 | 9.87% | Jefferies | $196 → $209 | Maintains | Hold | |||
10/05/2023 | 18.8% | Deutsche Bank | → $226 | Initiates | → Buy | |||
07/24/2023 | 5.66% | Citigroup | $197 → $201 | Maintains | Neutral | |||
07/24/2023 | 7.76% | Raymond James | $195 → $205 | Maintains | Outperform | |||
07/21/2023 | 7.76% | Morgan Stanley | $202 → $205 | Maintains | Equal-Weight | |||
07/21/2023 | 9.34% | Wells Fargo | $200 → $208 | Maintains | Overweight | |||
07/21/2023 | 10.39% | B of A Securities | $189 → $210 | Upgrade | Underperform → Neutral | |||
06/20/2023 | 6.19% | Morgan Stanley | → $202 | Initiates | → Equal-Weight | |||
06/08/2023 | 4.61% | Evercore ISI Group | $195 → $199 | Upgrade | In-Line → Outperform | |||
05/15/2023 | 0.93% | BMO Capital | $168 → $192 | Maintains | Market Perform | |||
04/21/2023 | -3.8% | RBC Capital | $180 → $183 | Maintains | Sector Perform | |||
04/21/2023 | 5.14% | Wells Fargo | $197 → $200 | Maintains | Overweight | |||
04/21/2023 | 3.56% | Citigroup | $192 → $197 | Maintains | Neutral | |||
04/21/2023 | 2.51% | Raymond James | $185 → $195 | Maintains | Outperform | |||
04/18/2023 | 0.93% | Citigroup | $190 → $192 | Maintains | Neutral | |||
04/13/2023 | -1.7% | Evercore ISI Group | $184 → $187 | Maintains | In-Line | |||
03/31/2023 | -4.85% | JP Morgan | $180 → $181 | Maintains | Neutral | |||
02/01/2023 | -0.12% | Citigroup | $185 → $190 | Maintains | Neutral | |||
01/30/2023 | -2.75% | Raymond James | $180 → $185 | Maintains | Outperform | |||
01/30/2023 | -9.58% | Credit Suisse | $157 → $172 | Maintains | Neutral | |||
01/27/2023 | -5.38% | RBC Capital | $170 → $180 | Maintains | Sector Perform | |||
01/27/2023 | 3.56% | Wells Fargo | $190 → $197 | Maintains | Overweight | |||
01/20/2023 | -11.69% | BMO Capital | → $168 | Initiates | → Market Perform | |||
01/18/2023 | -0.12% | Wells Fargo | $183 → $190 | Maintains | Overweight | |||
01/09/2023 | -6.43% | Jefferies | $181 → $178 | Downgrade | Buy → Hold | |||
12/23/2022 | -17.47% | Credit Suisse | → $157 | Initiates | → Neutral | |||
12/15/2022 | -2.75% | Citigroup | → $185 | Initiates | → Neutral | |||
11/22/2022 | -21.15% | Morgan Stanley | $145 → $150 | Maintains | Underweight | |||
11/08/2022 | -2.75% | Atlantic Equities | → $185 | Downgrade | Overweight → Neutral |
FAQ
Quel est le cours indicatif de l'action Marsh & McLennan Cos (MMC) ?
Le dernier objectif de prix pour Marsh & McLennan Cos (NYSE:MMC) a été rapporté par Goldman Sachs le octobre 20, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $195.00 s'attendant à ce que MMC se rise dans les 12 prochains mois (un possible changement de 2.51% upside). 35 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour Marsh & McLennan Cos (MMC) ?
La dernière note d'analyste pour Marsh & McLennan Cos (NYSE:MMC) a été fournie par Goldman Sachs, et Marsh & McLennan Cos amélioré leur note neutral.
Quand a eu lieu la dernière mise à niveau pour Marsh & McLennan Cos (MMC) ?
La dernière amélioration pour Marsh & McLennan Companies Inc a eu lieu le octobre 20, 2025 lorsque Goldman Sachs a augmenté leur objectif de prix à $195. Goldman Sachs avait précédemment a sell pour Marsh & McLennan Companies Inc.
Quand a eu lieu la dernière dégradation pour Marsh & McLennan Cos (MMC) ?
La dernière réduction pour Marsh & McLennan Companies Inc a eu lieu le avril 17, 2024 lorsque Piper Sandler a changé leur objectif de prix de N/A à $211 pour Marsh & McLennan Companies Inc.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour Marsh & McLennan Cos (MMC) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Marsh & McLennan Cos, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Marsh & McLennan Cos a été déposée le octobre 20, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers octobre 20, 2026.
La note d'analyste pour Marsh & McLennan Cos (MMC) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de Marsh & McLennan Cos (MMC) était un amélioré avec un objectif de prix de $200.00 à $195.00. Le prix actuel de Marsh & McLennan Cos (MMC) est de $190.23, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.